Exelon Co. (NASDAQ:EXC) Shares Sold by Kintegral Advisory LLC

Kintegral Advisory LLC lessened its stake in shares of Exelon Co. (NASDAQ:EXC) by 4.5% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 13,634 shares of the company’s stock after selling 635 shares during the quarter. Kintegral Advisory LLC’s holdings in Exelon were worth $513,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of EXC. State Street Corp boosted its holdings in shares of Exelon by 3.7% during the third quarter. State Street Corp now owns 60,169,219 shares of the company’s stock worth $2,439,862,000 after purchasing an additional 2,156,259 shares during the last quarter. Geode Capital Management LLC boosted its holdings in shares of Exelon by 1.6% during the third quarter. Geode Capital Management LLC now owns 25,945,791 shares of the company’s stock worth $1,048,823,000 after purchasing an additional 403,542 shares during the last quarter. FMR LLC boosted its holdings in shares of Exelon by 18.7% during the third quarter. FMR LLC now owns 11,782,549 shares of the company’s stock worth $477,782,000 after purchasing an additional 1,858,502 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Exelon by 1.8% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,967,343 shares of the company’s stock worth $363,626,000 after purchasing an additional 160,313 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its holdings in shares of Exelon by 2.0% during the third quarter. Charles Schwab Investment Management Inc. now owns 6,446,408 shares of the company’s stock worth $261,402,000 after purchasing an additional 123,466 shares during the last quarter. Institutional investors and hedge funds own 80.92% of the company’s stock.

Exelon Trading Up 0.5 %

NASDAQ:EXC opened at $43.39 on Monday. The business’s 50-day moving average is $39.41 and its two-hundred day moving average is $39.11. The company has a debt-to-equity ratio of 1.61, a current ratio of 0.87 and a quick ratio of 0.78. Exelon Co. has a 12 month low of $34.01 and a 12 month high of $43.69. The firm has a market capitalization of $43.62 billion, a PE ratio of 17.71, a price-to-earnings-growth ratio of 2.86 and a beta of 0.56.

Exelon (NASDAQ:EXC) last released its quarterly earnings data on Wednesday, February 12th. The company reported $0.64 EPS for the quarter, beating the consensus estimate of $0.59 by $0.05. Exelon had a return on equity of 9.52% and a net margin of 10.68%. During the same period last year, the firm earned $0.60 EPS. Research analysts predict that Exelon Co. will post 2.64 earnings per share for the current fiscal year.

Exelon Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 14th. Shareholders of record on Monday, February 24th will be given a $0.40 dividend. The ex-dividend date of this dividend is Monday, February 24th. This is a positive change from Exelon’s previous quarterly dividend of $0.38. This represents a $1.60 annualized dividend and a yield of 3.69%. Exelon’s dividend payout ratio (DPR) is 62.04%.

Insider Transactions at Exelon

In related news, EVP Colette D. Honorable sold 1,463 shares of the business’s stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $40.57, for a total value of $59,353.91. Following the completion of the sale, the executive vice president now directly owns 2,271 shares of the company’s stock, valued at $92,134.47. The trade was a 39.18 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.10% of the company’s stock.

Wall Street Analysts Forecast Growth

EXC has been the topic of several analyst reports. Barclays decreased their price objective on Exelon from $44.00 to $42.00 and set an “overweight” rating on the stock in a report on Wednesday, January 22nd. Morgan Stanley decreased their price objective on Exelon from $46.00 to $44.00 and set an “equal weight” rating on the stock in a report on Friday, November 22nd. Guggenheim upgraded Exelon from a “neutral” rating to a “buy” rating in a report on Thursday, January 23rd. Scotiabank lifted their target price on Exelon from $42.00 to $44.00 and gave the company a “sector perform” rating in a report on Thursday, February 13th. Finally, BMO Capital Markets reiterated an “outperform” rating on shares of Exelon in a report on Tuesday, February 4th. Five investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat.com, Exelon currently has an average rating of “Moderate Buy” and a consensus target price of $43.38.

Exelon Company Profile

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.